Pfizer's experimental cancer drug trial ends early

NCT ID NCT06799533

First seen Nov 01, 2025 · Last updated Jun 14, 2026 · Updated 35 times

Summary

This study tested a new drug, PF-08046031, in 11 adults with advanced melanoma or other solid tumors that had spread or had no standard treatment. The goal was to check safety and side effects, and to find the right dose. The trial was terminated early, so results are limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC MELANOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Gustave Roussy

    Villejuif, Val-de-marne, 94800, France

  • Hospital Universitari Vall d'Hebron

    Barcelona, Barcelona [barcelona], 08035, Spain

  • Karolinska Universitetssjukhuset Solna

    Solna, Stockholms LÄN [se-01], 171 64, Sweden

  • Presbyterian/ St. Lukes Medical Center

    Denver, Colorado, 80218, United States

  • Sarah Cannon Research Institute at HealthONE - SCRI - PPDS

    Denver, Colorado, 80218, United States

  • The Angeles Clinic And Research Institute, A Cedars-Sinai Affiliate

    Los Angeles, California, 90025, United States

  • The Angeles Clinic and Research Institue, A Cedars-Sinai Affiliate

    Los Angeles, California, 90025, United States

  • The Angeles Clinic and Research Institue, A Cedars-Sinai Affiliate (Emergency Back-up only)

    Santa Monica, California, 90404, United States

  • The Royal Marsden NHS Foundation Trust

    Sutton, SM2 5PT, United Kingdom

  • UCSF Helen Diller Family Comprehensive Cancer Center

    San Francisco, California, 94143, United States

  • UCSF Medical Center, Investigational Pharmacy

    San Francisco, California, 94158, United States

Conditions

Explore the condition pages connected to this study.